• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • Clinical Trial Listings
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Market Research
    • Benchmark Reports
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
  • White Papers
  • Clinical Trial Listings
  • Advertise
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Authors » Suz Redfearn

Articles by Suz Redfearn

Research Projects Show Credentialed Principal Investigators and CRCs Perform Better

July 2, 2018
Suz Redfearn
The research is clear: certified principal investigators (CPIs) and clinical research coordinators (CRCs) do better work compared with their peers who hold no certification. Much better work, in fact. Read More

As the Clinical Trials Industry Evolves, the Most Valued Skill Sets for Professionals are Changing

June 18, 2018
Suz Redfearn
Due to the vast influx of technology and the advent of Risk-Based Monitoring, the clinical research landscape is now evolving fast, and along with it, so are jobs in the field. Read More

Evolution of eConsent Technology Leads to Greater Adoption from Sponsors and Clinical Trials Sites

June 11, 2018
Suz Redfearn
eConsent has developed a reputation for being the next big technological innovation in clinical trials, and adoption efforts are accelerating. Read More

Big Data and Technology Increasingly the Focus of Clinical Trial Service Providers

June 4, 2018
Suz Redfearn
The media buzz last week on reported layoffs at IBM Watson Health ranged from calling it a “bloodbath” to something more surgical. Eventually, IBM Watson Health confirmed the layoffs at some of its acquired businesses, but wouldn’t say how many, and said it was continuing to hire in other new areas. Read More

Experts Offer Advice on Seeking Research Site Excellence in an Age of Complicated Protocols

May 29, 2018
Suz Redfearn
Despite endless talk over the last decade of ways to make clinical trials shorter and simpler, trials have only gotten longer and more complicated. Read More

As CTTI Turns 10, Executive Director Looks at Accomplishments and Shortcomings

May 21, 2018
Suz Redfearn
The Clinical Trials Transformation Initiative (CTTI)—the first consortium to pull widespread stakeholders together, including the FDA, to hash through and try to fix large-scale problems that have plagued the clinical research space—has turned 10. What has it accomplished? Read More

Tufts: Facing Many Challenges, Orphan Drugs Take 18% Longer to Develop

May 14, 2018
Suz Redfearn
Orphan drug development takes 15.1 years to go from first patent filing to product launch, 18 percent longer than the average time required for all new drugs, according to the Tufts Center for the Study of Drug Development. And development time for drugs to treat ultra-orphan diseases—which affect only a few hundred patients in the U.S.—is even longer: 17.2 years. Read More

Emphasis on Patients and Data Will Transform Clinical Trials Industry, Says Getz

May 7, 2018
Suz Redfearn
Clinical research is poised on the verge of a huge transformation driven by three factors: the patient engagement movement, rich data and analytics and the learning health system model. Read More

Clinical Trial Agreements: Do You Understand All the Important Terms in the Contract?

April 30, 2018
Suz Redfearn
Do you understand everything you need to about the clinical trial agreement contracts you sign? Read More

Becoming a Preferred Site: Stay Organized, Consistent and Go Beyond the Basics

April 30, 2018
Suz Redfearn
How does a site become irresistible to Sponsors and CROs? Read More
Previous 1 2 3 Next

Upcoming Events

  • 16Oct

    MAGI@home Clinical Research Conference 2023

  • 25Oct

    2023 WCG Patient Forum

  • 26Oct

    FDA in 2024: What to Expect in an Election Year

Featured Products

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

  • Best Practices for Clinical Trial Site Management

    Best Practices for Clinical Trial Site Management

Featured Stories

  • Donna Snyder

    New WCG Executive Physician Outlines Goals for Clinical Research

  • Hand Shake at Meeting

    Partnership to Bolster Trials in Low Resource Regions Kicks Off

  • Guidelines-360x240.png

    Major Industry Groups Offer Feedback on ICH’s E6(R3) Guidelines

  • AsktheExpertsBadge-360x240.png

    Ask the Experts: Monitoring

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell or Share My Data

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 703.538.7600 – Toll free 888.838.5578

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing